A Certificate of Analysis (CoA) is the primary quality document for research peptides, containing analytical data that verifies identity, purity, and composition of a specific production batch. Understanding how to critically read and evaluate a CoA is an essential skill for any researcher working with synthetic peptides.
Essential CoA Components
Header information: Product name, catalog number, batch/lot number, production date, and expiration date. The lot number is critical—it links your specific vial to the analytical data. If the lot number on your vial does not match the CoA, the data does not apply to your product.
Peptide identification: Amino acid sequence (one-letter or three-letter code), molecular formula, theoretical molecular weight, and any modifications (N-terminal acetylation, C-terminal amidation, disulfide bonds, non-standard amino acids). Verify that the stated sequence matches your target peptide exactly.
Appearance: Physical description (typically “white to off-white lyophilized powder”). Significant deviation (yellow discoloration, liquid, or clumped powder) may indicate degradation or improper handling.
HPLC Purity Data
The HPLC section is the most important part of the CoA for assessing peptide quality. A complete HPLC report should include: the purity percentage (area % of the main peak), the HPLC method parameters (column type, mobile phases, gradient program, flow rate, detection wavelength), and ideally the actual chromatogram image.
When reading the chromatogram, examine: the main peak shape (should be sharp and symmetrical—tailing or fronting indicates impurities co-eluting with the target), the baseline before and after the main peak (should be flat—a rising baseline suggests numerous minor impurities), and the presence of secondary peaks (each represents a specific impurity that can be investigated by collecting and analyzing the fraction).
Common HPLC pitfalls to watch for: detection at 280 nm instead of 214 nm (280 nm only detects aromatic residues, missing many peptide impurities), incomplete gradient elution (some impurities may not elute within the run time), and TFA-contaminated baselines that obscure low-level impurities. See our detailed HPLC testing guide for method interpretation specifics.
Mass Spectrometry Data
Mass spectrometry confirms peptide identity by measuring molecular weight. The CoA should report the observed mass and the theoretical mass, with agreement within ±1 Da for ESI-MS. Common mass discrepancies and their meanings: +80 Da (phosphorylation or sulfation), +16 Da (oxidation of Met or Trp), -18 Da (dehydration/cyclization), -17 Da (pyroglutamate formation from N-terminal Gln), +42 Da (acetylation), and mass differences corresponding to amino acid additions or deletions.
The mass spectrum itself should show a clean dominant peak at the expected m/z value(s). For peptides analyzed by ESI-MS, multiple charge states are normal ([M+2H]²⁺, [M+3H]³⁺, etc.) and can be deconvoluted to confirm molecular weight. Adduct peaks (sodium +22 Da, potassium +38 Da) are common but should not dominate the spectrum. Learn more in our mass spectrometry guide.
Net Peptide Content
This is one of the most commonly misunderstood CoA parameters. A vial labeled “5 mg” may contain 5 mg gross weight, but the actual peptide content is less due to counterions (TFA or acetate salts), residual water, and adsorbed salts. Net peptide content is typically 60-80% of gross weight for TFA-salt peptides and 80-90% for acetate-salt peptides.
For accurate dosing in research, researchers must use the net peptide content to calculate actual peptide mass. For example, 5 mg gross weight at 75% net peptide content provides 3.75 mg of actual peptide. Failing to account for this leads to systematically incorrect concentrations, affecting dose-response relationships and experimental reproducibility. Use our dosage calculator to compute adjusted concentrations.
Additional Quality Parameters
Amino acid analysis (AAA): Reports the molar ratio of each amino acid after acid hydrolysis. Theoretical and observed ratios should agree within ±10%. AAA cannot distinguish sequence order (just composition) and destroys Trp and partially destroys Cys during hydrolysis.
Water content: Measured by Karl Fischer titration. Typical values for lyophilized peptides are 2-8% w/w. Higher water content suggests inadequate lyophilization and may accelerate degradation.
Counterion content: TFA content can be measured by ion chromatography or 19F NMR. High TFA content (>15% w/w) is common for peptides purified by RP-HPLC with TFA-containing mobile phases. Some researchers prefer acetate-exchanged peptides for cell culture applications, as TFA can be cytotoxic at high concentrations.
Frequently Asked Questions
What should I do if the CoA does not include chromatograms or spectra?
Request them from the supplier. A CoA stating “purity: 98% by HPLC” without the actual chromatogram cannot be independently evaluated. Reputable suppliers routinely provide graphical analytical data. If a supplier refuses to provide chromatograms, consider this a significant red flag and evaluate alternative sources. See our red flags guide.
How do I verify that the CoA matches my specific vial?
Cross-reference the lot number on the vial label with the lot number on the CoA. These must match exactly. If your vial has no lot number, or the lot number does not appear on the CoA, the analytical data cannot be confirmed as applicable to your specific product. Some suppliers provide QR codes linking to batch-specific CoAs.
What purity is acceptable for different research applications?
Cell-based assays: ≥95%. Quantitative binding/activity assays: ≥98%. In vivo studies: ≥98% with endotoxin testing. Structural studies (NMR, crystallography): ≥99%. Immunization/antibody generation: ≥85% may be acceptable as the immune system responds to the target peptide within a mixture. Always match purity to your specific experimental requirements.